Nicotine Exposure during Adolescence Induces a Depression-Like State in Adulthood

被引:117
作者
Iniguez, Sergio D. [1 ]
Warren, Brandon L. [1 ]
Parise, Eric M. [1 ]
Alcantara, Lyonna F. [1 ]
Schuh, Brittney [1 ]
Maffeo, Melissa L. [1 ]
Manojlovic, Zarko [1 ]
Bolanos-Guzman, Carlos A. [1 ]
机构
[1] Florida State Univ, Dept Psychol, Program Neurosci, Tallahassee, FL 32306 USA
关键词
adolescence; bupropion; depression; fluoxetine; nicotine; rats; FORCED SWIMMING TEST; CIGARETTE-SMOKING; PSYCHIATRIC-DISORDERS; ANIMAL-MODEL; MOLECULAR NEUROBIOLOGY; BEHAVIORAL-RESPONSES; PSYCHOTROPIC-DRUGS; NUCLEUS-ACCUMBENS; TOBACCO ADDICTION; MAJOR DEPRESSION;
D O I
10.1038/npp.2008.220
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
There is a strong link between tobacco consumption and mood disorders. It has been suggested that afflicted individuals smoke to manage mood, however, there is evidence indicating that tobacco consumption can induce negative mood. This study was designed to investigate whether nicotine exposure during adolescence influences emotionality/behavioral functioning later in life. Adolescent (postnatal days, PD 30-44) male rats were treated with twice-daily injections of nicotine (0, 0.16, 0.32, or 0.64 mg/kg) for 15 consecutive days, and their behavioral reactivity to various behavioral paradigms the elevated plus maze (EPM), sucrose preference, locomotor activity in the open field, and forced swim test (FST) was assessed 24 h (short term) or 1-month (long term) after exposure. Separate groups of adult rats received nicotine (0.32 mg/kg) to control for age-dependent effects. We report that nicotine exposure during adolescence-but not adulthood-leads to a depression-like state manifested in decreased sensitivity to natural reward (sucrose), and enhanced sensitivity to stress-(FST) and anxiety-eliciting situations (EPM) later in life. Our data show that behavioral dysregulation can emerge 1 week after drug cessation, and that a single day of nicotine exposure during adolescence can be sufficient to precipitate a depression-like state in adulthood. We further demonstrate that these deficits can be normalized by subsequent nicotine (0.32 mg/kg) or antidepressant (ie fluoxetine or bupropion; 10 mg/kg) treatment in adulthood. These data suggest that adolescent exposure to nicotine results in a negative emotional state rendering the organism significantly more vulnerable to the adverse effects of stress. Within this context, our findings, together with others indicating that nicotine exposure during adolescence enhances risk for addiction later in life, could serve as a potential model of comorbidity.
引用
收藏
页码:1609 / 1624
页数:16
相关论文
共 113 条
[1]   Nicotine is a neurotoxin in the adolescent brain:: critical periods, patterns of exposure, regional selectivity, and dose thresholds for macromolecular alterations [J].
Abreu-Villaça, Y ;
Seidler, FJ ;
Tate, CA ;
Slotkin, TA .
BRAIN RESEARCH, 2003, 979 (1-2) :114-128
[2]   Windows of vulnerability to psychopathology and therapeutic strategy in the adolescent rodent model [J].
Adriani, W ;
Laviola, G .
BEHAVIOURAL PHARMACOLOGY, 2004, 15 (5-6) :341-352
[3]   Preexposure during or following adolescence differently affects nicotine-rewarding properties in adult rats [J].
Adriani, W ;
Deroche-Gamonet, V ;
Le Moal, M ;
Laviola, G ;
Piazza, PV .
PSYCHOPHARMACOLOGY, 2006, 184 (3-4) :382-390
[4]  
Adriani W, 2003, J NEUROSCI, V23, P4712
[5]   Smoking and young people's mental health [J].
Alvarado, GF ;
Breslau, N .
CURRENT OPINION IN PSYCHIATRY, 2005, 18 (04) :397-400
[6]   Altering the course of neurodevelopment: a framework for understanding the enduring effects of psychotropic drugs [J].
Andersen, SL ;
Navalta, CP .
INTERNATIONAL JOURNAL OF DEVELOPMENTAL NEUROSCIENCE, 2004, 22 (5-6) :423-440
[7]   Stress, sensitive periods and maturational events in adolescent depression [J].
Andersen, Susan L. ;
Teicher, Martin H. .
TRENDS IN NEUROSCIENCES, 2008, 31 (04) :183-191
[8]   A 'crash' course on psychostimulant withdrawal as a model of depression [J].
Barr, AM ;
Markou, A ;
Phillips, AG .
TRENDS IN PHARMACOLOGICAL SCIENCES, 2002, 23 (10) :475-482
[9]  
Barron Susan, 2005, Alcohol Clin Exp Res, V29, P1720, DOI 10.1097/01.alc.0000179220.79356.e5
[10]   Clinical pharmacology of nicotine: Implications for understanding, preventing, and treating tobacco addiction [J].
Benowitz, N. L. .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 2008, 83 (04) :531-541